|
Name: Fencamfamin
Type: Stimulant
AKA: Reactivan
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Fencamfamin, a stimulant, was developed in the mid-20th century. It was used for its stimulating effects and as a treatment for various conditions but has been largely discontinued due to potential side effects and abuse.
|
|
V. Legal Information
Fencamfamin is a stimulant drug used historically as an anorectic agent. It is controlled in many countries due to its potential for abuse and dependency. In the United States, it is not approved for medical use and is regulated under similar laws that control stimulants and appetite suppressants. [Source: UNODC].
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Fencamfamin is a stimulant with psychostimulant properties. It increases heart rate and blood pressure. Short-term use may improve focus and alertness, but long-term use can lead to cardiovascular issues, psychological problems, and dependency. Overdose risks include severe agitation, cardiovascular effects, and potential death. Safe use involves careful dosing and monitoring. Recent research highlights its stimulant effects and associated health risks.  |
|
VII. Psychological Effects
N/A
 |
|
VIII. Culture
Fencamfamin is a stimulant with psychoactive effects. Its cultural significance is linked to its use in recreational settings and its potential for abuse. Media coverage often focuses on the risks and effects of stimulant use, including health risks and addiction issues. Fencamfamin is used recreationally rather than medicinally and contributes to discussions about drug use and harm reduction.
 |